Loading clinical trials...

Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT02014883

Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS

The purpose of this project is to study the efficacy of triheptanoin oil in patients with GLUT1 deficiency syndrome.

Lead sponsor: Institut National de la Santé Et de la Recherche Médicale, France•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

COMPLETED

The Glucose Transporter Type I Deficiency (G1D) Registry

NCT02013583 · GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, and more

COMPLETEDPhase 1

Treatment Development of Triheptanoin (G1D)

NCT03041363 · Epilepsy, GLUT1DS1, and more

COMPLETEDNA

Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test

NCT03722212 · Glut1 Deficiency Syndrome, De Vivo Disease, and more

COMPLETEDPhase 1

Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)

NCT02018315 · Glucose Transporter Type 1 Deficiency Syndrome, GLUT1 Deficiency Syndrome

WITHDRAWNPhase 1/2

Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)

NCT02021526 · Glucose Transporter Type 1 Deficiency Syndrome, Glut1 Deficiency Syndrome

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 3, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment20

Start dateDec 2013

Last updatedOct 3, 2025

Condition

Glut1 Deficiency Syndrome

Locations shown

Brain and Spine Institute

Paris

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions